Conditional Mineralocorticoid Receptor Expression in the Heart Leads to Life-Threatening Arrhythmias
Author(s) -
Antoine OuvrardPascaud,
Yannis Sainte–Marie,
JeanPierre Bénitah,
Romain Perrier,
Christelle Soukaseum,
Aurélie Nguyen Dinh Cat,
Anne Royer,
Khaï Le Quang,
Flavien Charpentier,
Sophie Demolombe,
Fatima MechtaGrigoriou,
Ahmed Beggah,
Pierre MaisonBlanche,
M. E. Oblin,
Claude Delcayre,
Glenn I. Fishman,
Nicolette Farman,
Brigitte Escoubet,
Frédéric Jaisser
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.104.503706
Subject(s) - medicine , mineralocorticoid receptor , mineralocorticoid , endocrinology , receptor , cardiology
Life-threatening cardiac arrhythmia is a major source of mortality worldwide. Besides rare inherited monogenic diseases such as long-QT or Brugada syndromes, which reflect abnormalities in ion fluxes across cardiac ion channels as a final common pathway, arrhythmias are most frequently acquired and associated with heart disease. The mineralocorticoid hormone aldosterone is an important contributor to morbidity and mortality in heart failure, but its mechanisms of action are incompletely understood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom